Liquid Biopsies and the Future of Precision Oncology

Estonia: A Small Digitization Giant

Hannalore Taal, a digital professional from Estonia, discusses her journey from healthcare to digital health, Estonia's successful digital transformation, and the importance of user-centric design and agile methodologies in digital health initiatives. Together, we explore the role of digital identity in innovation, the need for digital skills and literacy, and the lessons learned from Estonia's experience that can be applied to other countries.

Assessing Digital Health Interventions

Together with my Guest Kathrin Cresswell, we delve into the complexities of digital health and implementation science. We discuss the importance of evaluations versus assessments, the challenges of digital health maturity assessments, user behaviours and the common reasons for failure in digital health interventions. The conversation also highlights the critical role of policy in the success of digital health initiatives and offers key recommendations for stakeholders in the healthcare sector.

The State of Digital Health in Mexico

Jesús takes us through the challenges and opportunities in digital health technology adoption in Mexico, focusing on the cultural, financial, and systemic barriers that hinder progress. We both discuss the importance of democratizing healthcare access, the role of clinical decision support systems, and provide practical advice for policymakers and healthcare professionals to enhance technology integration in the healthcare sector.

Building Bridges: The Human Side of Digital Health

Mehdi and Tjaša explore the evolving landscape of digital health, discussing personal experiences, innovations, and the challenges faced in the adoption of digital therapeutics. They delve into the importance of patient engagement, the role of technology in preventive care, and the complexities of data governance within the European Health Data Space. Tjaša emphasizes the need for human intervention in digital health solutions and the significance of preparing patients for medical visits to enhance their healthcare experience.

Liquid Biopsies and the Future of Precision Oncology

In this conversation, my guest Simranjit Singh, CEO of Guardant Health in Singapore, discusses his journey in revolutionizing cancer diagnostics through precision oncology and liquid biopsies. He highlights the importance of early detection in bending mortality curves and the challenges faced in navigating diverse regulatory landscapes across Asia. The impact of COVID-19 on the perception of diagnostics is explored, along with advancements in early detection methods. Simran emphasizes the need for collaboration and adaptability in the evolving landscape of precision medicine in Asia.